Cargando…

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

Since 2004, Georgia achieved universal access to free antiretroviral therapy (ART). A retrospective cohort study was conducted to evaluate the outcomes of Georgia's ART program. The study included adult patients enrolled in the ART program from 2004 through 2009. Of 752 patients, 76% were men,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsertsvadze, Tengiz, Chkhartishvili, Nikoloz, Sharvadze, Lali, Dvali, Natia, Chokoshvili, Otar, Gabunia, Pati, Abutidze, Akaki, Nelson, Kenrad, DeHovitz, Jack, del Rio, Carlos
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065882/
https://www.ncbi.nlm.nih.gov/pubmed/21490781
http://dx.doi.org/10.1155/2011/621078
_version_ 1782201032975056896
author Tsertsvadze, Tengiz
Chkhartishvili, Nikoloz
Sharvadze, Lali
Dvali, Natia
Chokoshvili, Otar
Gabunia, Pati
Abutidze, Akaki
Nelson, Kenrad
DeHovitz, Jack
del Rio, Carlos
author_facet Tsertsvadze, Tengiz
Chkhartishvili, Nikoloz
Sharvadze, Lali
Dvali, Natia
Chokoshvili, Otar
Gabunia, Pati
Abutidze, Akaki
Nelson, Kenrad
DeHovitz, Jack
del Rio, Carlos
author_sort Tsertsvadze, Tengiz
collection PubMed
description Since 2004, Georgia achieved universal access to free antiretroviral therapy (ART). A retrospective cohort study was conducted to evaluate the outcomes of Georgia's ART program. The study included adult patients enrolled in the ART program from 2004 through 2009. Of 752 patients, 76% were men, 60% were injection drug users (IDU), 59% had a history of an AIDS-defining illness, and 53% were coinfected with hepatitis C. The median baseline CD4 cell count was 141 cells/mm(3). During followup, 152 (20%) patients died, with the majority of deaths occurring within 12 months of ART initiation. Mortality was associated with advanced immunodeficiency or the presence of incurable disease at baseline. Among patients remaining on treatment, the median CD4 gain was 216 cell/mm(3) and 86% of patients had viral load <400 copies/ml at the last clinical visit. The Georgia ART program has been successful in treating injection drug users infected with HIV.
format Text
id pubmed-3065882
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30658822011-04-13 Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia Tsertsvadze, Tengiz Chkhartishvili, Nikoloz Sharvadze, Lali Dvali, Natia Chokoshvili, Otar Gabunia, Pati Abutidze, Akaki Nelson, Kenrad DeHovitz, Jack del Rio, Carlos AIDS Res Treat Research Article Since 2004, Georgia achieved universal access to free antiretroviral therapy (ART). A retrospective cohort study was conducted to evaluate the outcomes of Georgia's ART program. The study included adult patients enrolled in the ART program from 2004 through 2009. Of 752 patients, 76% were men, 60% were injection drug users (IDU), 59% had a history of an AIDS-defining illness, and 53% were coinfected with hepatitis C. The median baseline CD4 cell count was 141 cells/mm(3). During followup, 152 (20%) patients died, with the majority of deaths occurring within 12 months of ART initiation. Mortality was associated with advanced immunodeficiency or the presence of incurable disease at baseline. Among patients remaining on treatment, the median CD4 gain was 216 cell/mm(3) and 86% of patients had viral load <400 copies/ml at the last clinical visit. The Georgia ART program has been successful in treating injection drug users infected with HIV. Hindawi Publishing Corporation 2011 2011-02-21 /pmc/articles/PMC3065882/ /pubmed/21490781 http://dx.doi.org/10.1155/2011/621078 Text en Copyright © 2011 Tengiz Tsertsvadze et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tsertsvadze, Tengiz
Chkhartishvili, Nikoloz
Sharvadze, Lali
Dvali, Natia
Chokoshvili, Otar
Gabunia, Pati
Abutidze, Akaki
Nelson, Kenrad
DeHovitz, Jack
del Rio, Carlos
Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title_full Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title_fullStr Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title_full_unstemmed Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title_short Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
title_sort outcomes of universal access to antiretroviral therapy (art) in georgia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065882/
https://www.ncbi.nlm.nih.gov/pubmed/21490781
http://dx.doi.org/10.1155/2011/621078
work_keys_str_mv AT tsertsvadzetengiz outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT chkhartishvilinikoloz outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT sharvadzelali outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT dvalinatia outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT chokoshviliotar outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT gabuniapati outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT abutidzeakaki outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT nelsonkenrad outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT dehovitzjack outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia
AT delriocarlos outcomesofuniversalaccesstoantiretroviraltherapyartingeorgia